Potential of the Trifunctional Bispecific Antibody Surek Depends on Dendritic Cells: Rationale for a New Approach of Tumor Immunotherapy-Reference-Cited by-同舟云学术

Potential of the Trifunctional Bispecific Antibody Surek Depends on Dendritic Cells: Rationale for a New Approach of Tumor Immunotherapy

Published:2013-01 Issue:1 Volume:19 Page:54-61
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Eissler Nina,Mysliwietz Josef,Deppisch Nina,Ruf Peter,Lindhofer Horst,Mocikat Ralph

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2012.00140.pdf

Reference37 articles.

1. Banchereau J, et al. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767–811.

2. Melief CJ. (2008) Cancer immunotherapy by dendritic cells. Immunity. 29:372–83.

3. Valone FH, et al. (2001) Dendritic cell-based treatment of cancer: closing in on a cellular therapy. Cancer J. 7 Suppl 2:S53–61.

4. Engleman EG. (2003) Dendritic cell-based cancer immunotherapy. Semin. Oncol. 30:23–9.

5. Mocikat R, Selmayr M, Thierfelder S, Lindhofer H. (1997) Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity. Cancer Res. 57:2346–9.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model;Frontiers in Immunology;2023-01-09

2. Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question;Pharmaceutics;2022-06-11

3. Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy;Protein & Peptide Letters;2019-07-22

4. Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition;Oncotarget;2016-12-10

5. “NextGen” Biologics: Bispecific Antibodies and Emerging Clinical Results;Expert Opinion on Biological Therapy;2016-03-16